Activist 13D/13G Filings - LUMOS PHARMA INC. (LUMO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2020-02-14
3:21 pm
Purchase
13GNEWLINK GENETICS CORP
NLNK
Lion Point Capital LP3,114,733
8.3%
3,114,733increase
(New Position)
View
2020-02-13
5:26 pm
Sale
13GNEWLINK GENETICS CORP
NLNK
LUMOS PHARMA INC.
LUMO
690,531
1.8%
-1,343,189decrease
(-66.05%)
View
2020-02-13
11:33 am
Purchase
13GNEWLINK GENETICS CORP
NLNK
RENAISSANCE TECHNOLOGIES LLC2,938,038
7.87%
877,025increase
(+42.55%)
View
Goto Prev, 0, 1